Concord Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	10,549	12,001	10,169	8,532	7,129
Revenue Growth (YoY)	-12.10%	18.01%	19.20%	19.67%	15.56%
Cost of Revenue	3,619	4,317	3,498	1,921	1,719
Gross Profit	6,930	7,684	6,672	6,611	5,410
Selling, General & Admin	1,769	1,389	1,230	1,103	956.96
Other Operating Expenses	1,487	1,150	1,038	1,969	1,662
Operating Expenses	4,001	3,083	2,805	3,612	3,120
Operating Income	2,929	4,601	3,867	2,999	2,290
Interest Expense	-2.83	-5.29	-25.52	-45.1	-54.84
Interest & Investment Income	-	17.1	30.41	44.41	47.87
Earnings From Equity Investments	29.09	-13.22	33.71	19.59	-36.38
Currency Exchange Gain (Loss)	-	81.98	64.81	102.22	63.59
Other Non Operating Income (Expenses)	523.55	43.54	12.79	57.93	9.73
EBT Excluding Unusual Items	3,479	4,725	3,983	3,178	2,320
Gain (Loss) on Sale of Investments	-	222.64	140.65	37.17	52.3
Gain (Loss) on Sale of Assets	-	-2.25	0.12	-0.94	-0.34
Other Unusual Items	-32.75	-	-	-0.31	-
Pretax Income	3,446	4,946	4,126	3,220	2,375
Income Tax Expense	854.18	1,229	1,045	819.28	625.89
Earnings From Continuing Operations	2,592	3,716	3,081	2,401	1,749
Minority Interest in Earnings	16.77	-	-	-	-
Net Income	2,609	3,716	3,081	2,401	1,749
Net Income to Common	2,609	3,716	3,081	2,401	1,749
Net Income Growth	-29.80%	20.62%	28.33%	37.25%	-25.53%
Shares Outstanding (Basic)	105	105	105	105	105
Shares Outstanding (Diluted)	105	105	105	105	105
Shares Change (YoY)	0.64%	-	-	-	-
EPS (Basic)	24.78	35.52	29.45	22.95	16.72
EPS (Diluted)	24.78	35.52	29.45	22.95	16.72
EPS Growth	-30.25%	20.62%	28.33%	37.25%	-25.52%
Free Cash Flow	1,717	1,333	1,798	1,009	526.36
Free Cash Flow Per Share	16.31	12.75	17.18	9.65	5.03
Dividend Per Share	7.550	10.700	8.750	6.830	5.120
Dividend Growth	-29.44%	22.29%	28.11%	33.40%	-24.05%
Gross Margin	65.70%	64.03%	65.61%	77.49%	75.89%
Operating Margin	27.77%	38.34%	38.03%	35.15%	32.12%
Profit Margin	24.73%	30.97%	30.30%	28.14%	24.54%
Free Cash Flow Margin	16.28%	11.11%	17.68%	11.83%	7.38%
EBITDA	3,674	5,127	4,386	3,527	2,778
EBITDA Margin	34.83%	42.72%	43.13%	41.33%	38.97%
D&A For EBITDA	744.59	526.08	518.51	527.85	487.98
EBIT	2,929	4,601	3,867	2,999	2,290
EBIT Margin	27.77%	38.34%	38.03%	35.15%	32.12%
Effective Tax Rate	24.78%	24.85%	25.32%	25.44%	26.35%
Revenue as Reported	11,072	12,445	10,507	8,885	7,364